Metabolic Biomarker Testing Market to 2027 - Global Analysis and Forecasts by Indication (Cancer, Cardiovascular Disorders, Neurological Disorders, Inborn Errors of Metabolism, Others); Application (Drug Discovery, Nutrigenomics, Toxicology Testing, Personalized Medicine, Functional Genomics, others); Technique (Separation Techniques, Detection Techniques, others); End-User (Pharma and Biotech Companies, Diagnostic Tool Companies, Healthcare IT, Clinical Laboratories.)
Report Code: TIPRE00004549 No. of Pages: 150 Category: Biotechnology Status: Upcoming
MARKET INTRODUCTION
Metabolic Biomarker Testing is a process that is associated with identification and quantification of metabolites in a particular biological system. The steps involved in the process are profiling, identification, quantification, and interpretation.
MARKET DYNAMICS
The Metabolic Biomarker Testing market is anticipated to grow in the forecast period owing to driving factors such as increasing demand for personalized medicines, increasing need for toxicology technologies, growing government research funding and initiatives and escalated R&D activities across various sectors.
MARKET SCOPE
The "Global Metabolic Biomarker Testing Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of Metabolic Biomarker Testing market with detailed market segmentation by Product, Biomaterial and geography. The global Metabolic Biomarker Testing market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Metabolic Biomarker Testing market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global Metabolic Biomarker Testing market is segmented on the basis of Indication, Application, Technique and End-User. Based on Indication the market is segmented into Cancer, Cardiovascular Disorders, Neurological Disorders, Inborn Errors of Metabolism, Others. Based on Application the market is segmented into Drug Discovery, Nutrigenomics, Toxicology Testing, Personalized Medicine, Functional Genomics, others. Based on Technique the market is segmented into Separation Techniques, Detection Techniques, others. Based on End User the market is segmented into Pharma and Biotech Companies, Diagnostic Tool Companies, Healthcare IT, Clinical Laboratories.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Metabolic Biomarker Testing market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Metabolic Biomarker Testing market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Metabolic Biomarker Testing market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Metabolic Biomarker Testing market in these regions.
MARKET PLAYERS
The reports cover key developments in the Metabolic Biomarker Testing Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Metabolic Biomarker Testing Market are anticipated to lucrative growth opportunities in the future with the rising demand for Metabolic Biomarker Testing in the global market. Below mentioned is the list of few companies engaged in the Metabolic Biomarker Testing market.
The report also includes the profiles of key Metabolic Biomarker Testing market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
Metabolic Biomarker Testing is a process that is associated with identification and quantification of metabolites in a particular biological system. The steps involved in the process are profiling, identification, quantification, and interpretation.
MARKET DYNAMICS
The Metabolic Biomarker Testing market is anticipated to grow in the forecast period owing to driving factors such as increasing demand for personalized medicines, increasing need for toxicology technologies, growing government research funding and initiatives and escalated R&D activities across various sectors.
MARKET SCOPE
The "Global Metabolic Biomarker Testing Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of Metabolic Biomarker Testing market with detailed market segmentation by Product, Biomaterial and geography. The global Metabolic Biomarker Testing market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Metabolic Biomarker Testing market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global Metabolic Biomarker Testing market is segmented on the basis of Indication, Application, Technique and End-User. Based on Indication the market is segmented into Cancer, Cardiovascular Disorders, Neurological Disorders, Inborn Errors of Metabolism, Others. Based on Application the market is segmented into Drug Discovery, Nutrigenomics, Toxicology Testing, Personalized Medicine, Functional Genomics, others. Based on Technique the market is segmented into Separation Techniques, Detection Techniques, others. Based on End User the market is segmented into Pharma and Biotech Companies, Diagnostic Tool Companies, Healthcare IT, Clinical Laboratories.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Metabolic Biomarker Testing market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Metabolic Biomarker Testing market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Metabolic Biomarker Testing market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Metabolic Biomarker Testing market in these regions.
The reports cover key developments in the Metabolic Biomarker Testing Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Metabolic Biomarker Testing Market are anticipated to lucrative growth opportunities in the future with the rising demand for Metabolic Biomarker Testing in the global market. Below mentioned is the list of few companies engaged in the Metabolic Biomarker Testing market.
The report also includes the profiles of key Metabolic Biomarker Testing market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Bio-Rad Laboratories, Inc
- Bruker Corporation
- Danaher Corporation
- Agilent Technologies
- Thermo Fisher Scientific, Inc
- Human Metabolome Technologies Inc
- LECO Corporation
- Shimadzu Corporation
- Biocrates Life Sciences AG
- Waters Corporation
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Metabolic Biomarker Testing Market - By Indication
1.3.2 Metabolic Biomarker Testing Market - By Application
1.3.3 Metabolic Biomarker Testing Market - By Technique
1.3.4 Metabolic Biomarker Testing Market - By End-User
1.3.5 Metabolic Biomarker Testing Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. METABOLIC BIOMARKER TESTING MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. METABOLIC BIOMARKER TESTING MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. METABOLIC BIOMARKER TESTING MARKET - GLOBAL MARKET ANALYSIS
6.1. METABOLIC BIOMARKER TESTING - GLOBAL MARKET OVERVIEW
6.2. METABOLIC BIOMARKER TESTING - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. METABOLIC BIOMARKER TESTING MARKET - REVENUE AND FORECASTS TO 2027 - INDICATION
7.1. OVERVIEW
7.2. INDICATION MARKET FORECASTS AND ANALYSIS
7.3. CANCER
7.3.1. Overview
7.3.2. Cancer Market Forecast and Analysis
7.4. CARDIOVASCULAR DISORDERS
7.4.1. Overview
7.4.2. Cardiovascular Disorders Market Forecast and Analysis
7.5. NEUROLOGICAL DISORDERS
7.5.1. Overview
7.5.2. Neurological Disorders Market Forecast and Analysis
7.6. INBORN ERRORS OF METABOLISM
7.6.1. Overview
7.6.2. Inborn Errors of Metabolism Market Forecast and Analysis
7.7. OTHERS
7.7.1. Overview
7.7.2. Others Market Forecast and Analysis
8. METABOLIC BIOMARKER TESTING MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. DRUG DISCOVERY
8.3.1. Overview
8.3.2. Drug Discovery Market Forecast and Analysis
8.4. NUTRIGENOMICS
8.4.1. Overview
8.4.2. Nutrigenomics Market Forecast and Analysis
8.5. TOXICOLOGY TESTING
8.5.1. Overview
8.5.2. Toxicology Testing Market Forecast and Analysis
8.6. PERSONALIZED MEDICINE
8.6.1. Overview
8.6.2. Personalized Medicine Market Forecast and Analysis
8.7. FUNCTIONAL GENOMICS
8.7.1. Overview
8.7.2. Functional Genomics Market Forecast and Analysis
8.8. OTHERS
8.8.1. Overview
8.8.2. others Market Forecast and Analysis
9. METABOLIC BIOMARKER TESTING MARKET - REVENUE AND FORECASTS TO 2027 - TECHNIQUE
9.1. OVERVIEW
9.2. TECHNIQUE MARKET FORECASTS AND ANALYSIS
9.3. SEPARATION TECHNIQUES
9.3.1. Overview
9.3.2. Separation Techniques Market Forecast and Analysis
9.4. DETECTION TECHNIQUES
9.4.1. Overview
9.4.2. Detection Techniques Market Forecast and Analysis
9.5. OTHERS
9.5.1. Overview
9.5.2. others Market Forecast and Analysis
10. METABOLIC BIOMARKER TESTING MARKET - REVENUE AND FORECASTS TO 2027 - END-USER
10.1. OVERVIEW
10.2. END-USER MARKET FORECASTS AND ANALYSIS
10.3. PHARMA AND BIOTECH COMPANIES
10.3.1. Overview
10.3.2. Pharma and Biotech Companies Market Forecast and Analysis
10.4. DIAGNOSTIC TOOL COMPANIES
10.4.1. Overview
10.4.2. Diagnostic Tool Companies Market Forecast and Analysis
10.5. HEALTHCARE IT
10.5.1. Overview
10.5.2. Healthcare IT Market Forecast and Analysis
10.6. CLINICAL LABORATORIES.
10.6.1. Overview
10.6.2. Clinical Laboratories. Market Forecast and Analysis
11. METABOLIC BIOMARKER TESTING MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Metabolic Biomarker Testing Market Overview
11.1.2 North America Metabolic Biomarker Testing Market Forecasts and Analysis
11.1.3 North America Metabolic Biomarker Testing Market Forecasts and Analysis - By Indication
11.1.4 North America Metabolic Biomarker Testing Market Forecasts and Analysis - By Application
11.1.5 North America Metabolic Biomarker Testing Market Forecasts and Analysis - By Technique
11.1.6 North America Metabolic Biomarker Testing Market Forecasts and Analysis - By End-User
11.1.7 North America Metabolic Biomarker Testing Market Forecasts and Analysis - By Countries
11.1.7.1 United States Metabolic Biomarker Testing Market
11.1.7.1.1 United States Metabolic Biomarker Testing Market by Indication
11.1.7.1.2 United States Metabolic Biomarker Testing Market by Application
11.1.7.1.3 United States Metabolic Biomarker Testing Market by Technique
11.1.7.1.4 United States Metabolic Biomarker Testing Market by End-User
11.1.7.2 Canada Metabolic Biomarker Testing Market
11.1.7.2.1 Canada Metabolic Biomarker Testing Market by Indication
11.1.7.2.2 Canada Metabolic Biomarker Testing Market by Application
11.1.7.2.3 Canada Metabolic Biomarker Testing Market by Technique
11.1.7.2.4 Canada Metabolic Biomarker Testing Market by End-User
11.1.7.3 Mexico Metabolic Biomarker Testing Market
11.1.7.3.1 Mexico Metabolic Biomarker Testing Market by Indication
11.1.7.3.2 Mexico Metabolic Biomarker Testing Market by Application
11.1.7.3.3 Mexico Metabolic Biomarker Testing Market by Technique
11.1.7.3.4 Mexico Metabolic Biomarker Testing Market by End-User
11.1.7.4 US Metabolic Biomarker Testing Market
11.1.7.4.1 US Metabolic Biomarker Testing Market by Indication
11.1.7.4.2 US Metabolic Biomarker Testing Market by Application
11.1.7.4.3 US Metabolic Biomarker Testing Market by Technique
11.1.7.4.4 US Metabolic Biomarker Testing Market by End-User
11.2. EUROPE
11.2.1 Europe Metabolic Biomarker Testing Market Overview
11.2.2 Europe Metabolic Biomarker Testing Market Forecasts and Analysis
11.2.3 Europe Metabolic Biomarker Testing Market Forecasts and Analysis - By Indication
11.2.4 Europe Metabolic Biomarker Testing Market Forecasts and Analysis - By Application
11.2.5 Europe Metabolic Biomarker Testing Market Forecasts and Analysis - By Technique
11.2.6 Europe Metabolic Biomarker Testing Market Forecasts and Analysis - By End-User
11.2.7 Europe Metabolic Biomarker Testing Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Metabolic Biomarker Testing Market
11.2.7.1.1 Germany Metabolic Biomarker Testing Market by Indication
11.2.7.1.2 Germany Metabolic Biomarker Testing Market by Application
11.2.7.1.3 Germany Metabolic Biomarker Testing Market by Technique
11.2.7.1.4 Germany Metabolic Biomarker Testing Market by End-User
11.2.7.2 France Metabolic Biomarker Testing Market
11.2.7.2.1 France Metabolic Biomarker Testing Market by Indication
11.2.7.2.2 France Metabolic Biomarker Testing Market by Application
11.2.7.2.3 France Metabolic Biomarker Testing Market by Technique
11.2.7.2.4 France Metabolic Biomarker Testing Market by End-User
11.2.7.3 Italy Metabolic Biomarker Testing Market
11.2.7.3.1 Italy Metabolic Biomarker Testing Market by Indication
11.2.7.3.2 Italy Metabolic Biomarker Testing Market by Application
11.2.7.3.3 Italy Metabolic Biomarker Testing Market by Technique
11.2.7.3.4 Italy Metabolic Biomarker Testing Market by End-User
11.2.7.4 Spain Metabolic Biomarker Testing Market
11.2.7.4.1 Spain Metabolic Biomarker Testing Market by Indication
11.2.7.4.2 Spain Metabolic Biomarker Testing Market by Application
11.2.7.4.3 Spain Metabolic Biomarker Testing Market by Technique
11.2.7.4.4 Spain Metabolic Biomarker Testing Market by End-User
11.2.7.5 United Kingdom Metabolic Biomarker Testing Market
11.2.7.5.1 United Kingdom Metabolic Biomarker Testing Market by Indication
11.2.7.5.2 United Kingdom Metabolic Biomarker Testing Market by Application
11.2.7.5.3 United Kingdom Metabolic Biomarker Testing Market by Technique
11.2.7.5.4 United Kingdom Metabolic Biomarker Testing Market by End-User
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Metabolic Biomarker Testing Market Overview
11.3.2 Asia-Pacific Metabolic Biomarker Testing Market Forecasts and Analysis
11.3.3 Asia-Pacific Metabolic Biomarker Testing Market Forecasts and Analysis - By Indication
11.3.4 Asia-Pacific Metabolic Biomarker Testing Market Forecasts and Analysis - By Application
11.3.5 Asia-Pacific Metabolic Biomarker Testing Market Forecasts and Analysis - By Technique
11.3.6 Asia-Pacific Metabolic Biomarker Testing Market Forecasts and Analysis - By End-User
11.3.7 Asia-Pacific Metabolic Biomarker Testing Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Metabolic Biomarker Testing Market
11.3.7.1.1 Australia Metabolic Biomarker Testing Market by Indication
11.3.7.1.2 Australia Metabolic Biomarker Testing Market by Application
11.3.7.1.3 Australia Metabolic Biomarker Testing Market by Technique
11.3.7.1.4 Australia Metabolic Biomarker Testing Market by End-User
11.3.7.2 China Metabolic Biomarker Testing Market
11.3.7.2.1 China Metabolic Biomarker Testing Market by Indication
11.3.7.2.2 China Metabolic Biomarker Testing Market by Application
11.3.7.2.3 China Metabolic Biomarker Testing Market by Technique
11.3.7.2.4 China Metabolic Biomarker Testing Market by End-User
11.3.7.3 India Metabolic Biomarker Testing Market
11.3.7.3.1 India Metabolic Biomarker Testing Market by Indication
11.3.7.3.2 India Metabolic Biomarker Testing Market by Application
11.3.7.3.3 India Metabolic Biomarker Testing Market by Technique
11.3.7.3.4 India Metabolic Biomarker Testing Market by End-User
11.3.7.4 Japan Metabolic Biomarker Testing Market
11.3.7.4.1 Japan Metabolic Biomarker Testing Market by Indication
11.3.7.4.2 Japan Metabolic Biomarker Testing Market by Application
11.3.7.4.3 Japan Metabolic Biomarker Testing Market by Technique
11.3.7.4.4 Japan Metabolic Biomarker Testing Market by End-User
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Metabolic Biomarker Testing Market Overview
11.4.2 Middle East and Africa Metabolic Biomarker Testing Market Forecasts and Analysis
11.4.3 Middle East and Africa Metabolic Biomarker Testing Market Forecasts and Analysis - By Indication
11.4.4 Middle East and Africa Metabolic Biomarker Testing Market Forecasts and Analysis - By Application
11.4.5 Middle East and Africa Metabolic Biomarker Testing Market Forecasts and Analysis - By Technique
11.4.6 Middle East and Africa Metabolic Biomarker Testing Market Forecasts and Analysis - By End-User
11.4.7 Middle East and Africa Metabolic Biomarker Testing Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Metabolic Biomarker Testing Market
11.4.7.1.1 South Africa Metabolic Biomarker Testing Market by Indication
11.4.7.1.2 South Africa Metabolic Biomarker Testing Market by Application
11.4.7.1.3 South Africa Metabolic Biomarker Testing Market by Technique
11.4.7.1.4 South Africa Metabolic Biomarker Testing Market by End-User
11.4.7.2 Saudi Arabia Metabolic Biomarker Testing Market
11.4.7.2.1 Saudi Arabia Metabolic Biomarker Testing Market by Indication
11.4.7.2.2 Saudi Arabia Metabolic Biomarker Testing Market by Application
11.4.7.2.3 Saudi Arabia Metabolic Biomarker Testing Market by Technique
11.4.7.2.4 Saudi Arabia Metabolic Biomarker Testing Market by End-User
11.4.7.3 U.A.E Metabolic Biomarker Testing Market
11.4.7.3.1 U.A.E Metabolic Biomarker Testing Market by Indication
11.4.7.3.2 U.A.E Metabolic Biomarker Testing Market by Application
11.4.7.3.3 U.A.E Metabolic Biomarker Testing Market by Technique
11.4.7.3.4 U.A.E Metabolic Biomarker Testing Market by End-User
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Metabolic Biomarker Testing Market Overview
11.5.2 South and Central America Metabolic Biomarker Testing Market Forecasts and Analysis
11.5.3 South and Central America Metabolic Biomarker Testing Market Forecasts and Analysis - By Indication
11.5.4 South and Central America Metabolic Biomarker Testing Market Forecasts and Analysis - By Application
11.5.5 South and Central America Metabolic Biomarker Testing Market Forecasts and Analysis - By Technique
11.5.6 South and Central America Metabolic Biomarker Testing Market Forecasts and Analysis - By End-User
11.5.7 South and Central America Metabolic Biomarker Testing Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Metabolic Biomarker Testing Market
11.5.7.1.1 Brazil Metabolic Biomarker Testing Market by Indication
11.5.7.1.2 Brazil Metabolic Biomarker Testing Market by Application
11.5.7.1.3 Brazil Metabolic Biomarker Testing Market by Technique
11.5.7.1.4 Brazil Metabolic Biomarker Testing Market by End-User
11.5.7.2 Argentina Metabolic Biomarker Testing Market
11.5.7.2.1 Argentina Metabolic Biomarker Testing Market by Indication
11.5.7.2.2 Argentina Metabolic Biomarker Testing Market by Application
11.5.7.2.3 Argentina Metabolic Biomarker Testing Market by Technique
11.5.7.2.4 Argentina Metabolic Biomarker Testing Market by End-User
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. METABOLIC BIOMARKER TESTING MARKET, KEY COMPANY PROFILES
13.1. BIO-RAD LABORATORIES, INC
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. BRUKER CORPORATION
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. DANAHER CORPORATION
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. AGILENT TECHNOLOGIES
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. THERMO FISHER SCIENTIFIC, INC
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. HUMAN METABOLOME TECHNOLOGIES INC
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. LECO CORPORATION
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. SHIMADZU CORPORATION
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. BIOCRATES LIFE SCIENCES AG
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. WATERS CORPORATION
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Metabolic Biomarker Testing Market - By Indication
1.3.2 Metabolic Biomarker Testing Market - By Application
1.3.3 Metabolic Biomarker Testing Market - By Technique
1.3.4 Metabolic Biomarker Testing Market - By End-User
1.3.5 Metabolic Biomarker Testing Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. METABOLIC BIOMARKER TESTING MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. METABOLIC BIOMARKER TESTING MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. METABOLIC BIOMARKER TESTING MARKET - GLOBAL MARKET ANALYSIS
6.1. METABOLIC BIOMARKER TESTING - GLOBAL MARKET OVERVIEW
6.2. METABOLIC BIOMARKER TESTING - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. METABOLIC BIOMARKER TESTING MARKET - REVENUE AND FORECASTS TO 2027 - INDICATION
7.1. OVERVIEW
7.2. INDICATION MARKET FORECASTS AND ANALYSIS
7.3. CANCER
7.3.1. Overview
7.3.2. Cancer Market Forecast and Analysis
7.4. CARDIOVASCULAR DISORDERS
7.4.1. Overview
7.4.2. Cardiovascular Disorders Market Forecast and Analysis
7.5. NEUROLOGICAL DISORDERS
7.5.1. Overview
7.5.2. Neurological Disorders Market Forecast and Analysis
7.6. INBORN ERRORS OF METABOLISM
7.6.1. Overview
7.6.2. Inborn Errors of Metabolism Market Forecast and Analysis
7.7. OTHERS
7.7.1. Overview
7.7.2. Others Market Forecast and Analysis
8. METABOLIC BIOMARKER TESTING MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. DRUG DISCOVERY
8.3.1. Overview
8.3.2. Drug Discovery Market Forecast and Analysis
8.4. NUTRIGENOMICS
8.4.1. Overview
8.4.2. Nutrigenomics Market Forecast and Analysis
8.5. TOXICOLOGY TESTING
8.5.1. Overview
8.5.2. Toxicology Testing Market Forecast and Analysis
8.6. PERSONALIZED MEDICINE
8.6.1. Overview
8.6.2. Personalized Medicine Market Forecast and Analysis
8.7. FUNCTIONAL GENOMICS
8.7.1. Overview
8.7.2. Functional Genomics Market Forecast and Analysis
8.8. OTHERS
8.8.1. Overview
8.8.2. others Market Forecast and Analysis
9. METABOLIC BIOMARKER TESTING MARKET - REVENUE AND FORECASTS TO 2027 - TECHNIQUE
9.1. OVERVIEW
9.2. TECHNIQUE MARKET FORECASTS AND ANALYSIS
9.3. SEPARATION TECHNIQUES
9.3.1. Overview
9.3.2. Separation Techniques Market Forecast and Analysis
9.4. DETECTION TECHNIQUES
9.4.1. Overview
9.4.2. Detection Techniques Market Forecast and Analysis
9.5. OTHERS
9.5.1. Overview
9.5.2. others Market Forecast and Analysis
10. METABOLIC BIOMARKER TESTING MARKET - REVENUE AND FORECASTS TO 2027 - END-USER
10.1. OVERVIEW
10.2. END-USER MARKET FORECASTS AND ANALYSIS
10.3. PHARMA AND BIOTECH COMPANIES
10.3.1. Overview
10.3.2. Pharma and Biotech Companies Market Forecast and Analysis
10.4. DIAGNOSTIC TOOL COMPANIES
10.4.1. Overview
10.4.2. Diagnostic Tool Companies Market Forecast and Analysis
10.5. HEALTHCARE IT
10.5.1. Overview
10.5.2. Healthcare IT Market Forecast and Analysis
10.6. CLINICAL LABORATORIES.
10.6.1. Overview
10.6.2. Clinical Laboratories. Market Forecast and Analysis
11. METABOLIC BIOMARKER TESTING MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Metabolic Biomarker Testing Market Overview
11.1.2 North America Metabolic Biomarker Testing Market Forecasts and Analysis
11.1.3 North America Metabolic Biomarker Testing Market Forecasts and Analysis - By Indication
11.1.4 North America Metabolic Biomarker Testing Market Forecasts and Analysis - By Application
11.1.5 North America Metabolic Biomarker Testing Market Forecasts and Analysis - By Technique
11.1.6 North America Metabolic Biomarker Testing Market Forecasts and Analysis - By End-User
11.1.7 North America Metabolic Biomarker Testing Market Forecasts and Analysis - By Countries
11.1.7.1 United States Metabolic Biomarker Testing Market
11.1.7.1.1 United States Metabolic Biomarker Testing Market by Indication
11.1.7.1.2 United States Metabolic Biomarker Testing Market by Application
11.1.7.1.3 United States Metabolic Biomarker Testing Market by Technique
11.1.7.1.4 United States Metabolic Biomarker Testing Market by End-User
11.1.7.2 Canada Metabolic Biomarker Testing Market
11.1.7.2.1 Canada Metabolic Biomarker Testing Market by Indication
11.1.7.2.2 Canada Metabolic Biomarker Testing Market by Application
11.1.7.2.3 Canada Metabolic Biomarker Testing Market by Technique
11.1.7.2.4 Canada Metabolic Biomarker Testing Market by End-User
11.1.7.3 Mexico Metabolic Biomarker Testing Market
11.1.7.3.1 Mexico Metabolic Biomarker Testing Market by Indication
11.1.7.3.2 Mexico Metabolic Biomarker Testing Market by Application
11.1.7.3.3 Mexico Metabolic Biomarker Testing Market by Technique
11.1.7.3.4 Mexico Metabolic Biomarker Testing Market by End-User
11.1.7.4 US Metabolic Biomarker Testing Market
11.1.7.4.1 US Metabolic Biomarker Testing Market by Indication
11.1.7.4.2 US Metabolic Biomarker Testing Market by Application
11.1.7.4.3 US Metabolic Biomarker Testing Market by Technique
11.1.7.4.4 US Metabolic Biomarker Testing Market by End-User
11.2. EUROPE
11.2.1 Europe Metabolic Biomarker Testing Market Overview
11.2.2 Europe Metabolic Biomarker Testing Market Forecasts and Analysis
11.2.3 Europe Metabolic Biomarker Testing Market Forecasts and Analysis - By Indication
11.2.4 Europe Metabolic Biomarker Testing Market Forecasts and Analysis - By Application
11.2.5 Europe Metabolic Biomarker Testing Market Forecasts and Analysis - By Technique
11.2.6 Europe Metabolic Biomarker Testing Market Forecasts and Analysis - By End-User
11.2.7 Europe Metabolic Biomarker Testing Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Metabolic Biomarker Testing Market
11.2.7.1.1 Germany Metabolic Biomarker Testing Market by Indication
11.2.7.1.2 Germany Metabolic Biomarker Testing Market by Application
11.2.7.1.3 Germany Metabolic Biomarker Testing Market by Technique
11.2.7.1.4 Germany Metabolic Biomarker Testing Market by End-User
11.2.7.2 France Metabolic Biomarker Testing Market
11.2.7.2.1 France Metabolic Biomarker Testing Market by Indication
11.2.7.2.2 France Metabolic Biomarker Testing Market by Application
11.2.7.2.3 France Metabolic Biomarker Testing Market by Technique
11.2.7.2.4 France Metabolic Biomarker Testing Market by End-User
11.2.7.3 Italy Metabolic Biomarker Testing Market
11.2.7.3.1 Italy Metabolic Biomarker Testing Market by Indication
11.2.7.3.2 Italy Metabolic Biomarker Testing Market by Application
11.2.7.3.3 Italy Metabolic Biomarker Testing Market by Technique
11.2.7.3.4 Italy Metabolic Biomarker Testing Market by End-User
11.2.7.4 Spain Metabolic Biomarker Testing Market
11.2.7.4.1 Spain Metabolic Biomarker Testing Market by Indication
11.2.7.4.2 Spain Metabolic Biomarker Testing Market by Application
11.2.7.4.3 Spain Metabolic Biomarker Testing Market by Technique
11.2.7.4.4 Spain Metabolic Biomarker Testing Market by End-User
11.2.7.5 United Kingdom Metabolic Biomarker Testing Market
11.2.7.5.1 United Kingdom Metabolic Biomarker Testing Market by Indication
11.2.7.5.2 United Kingdom Metabolic Biomarker Testing Market by Application
11.2.7.5.3 United Kingdom Metabolic Biomarker Testing Market by Technique
11.2.7.5.4 United Kingdom Metabolic Biomarker Testing Market by End-User
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Metabolic Biomarker Testing Market Overview
11.3.2 Asia-Pacific Metabolic Biomarker Testing Market Forecasts and Analysis
11.3.3 Asia-Pacific Metabolic Biomarker Testing Market Forecasts and Analysis - By Indication
11.3.4 Asia-Pacific Metabolic Biomarker Testing Market Forecasts and Analysis - By Application
11.3.5 Asia-Pacific Metabolic Biomarker Testing Market Forecasts and Analysis - By Technique
11.3.6 Asia-Pacific Metabolic Biomarker Testing Market Forecasts and Analysis - By End-User
11.3.7 Asia-Pacific Metabolic Biomarker Testing Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Metabolic Biomarker Testing Market
11.3.7.1.1 Australia Metabolic Biomarker Testing Market by Indication
11.3.7.1.2 Australia Metabolic Biomarker Testing Market by Application
11.3.7.1.3 Australia Metabolic Biomarker Testing Market by Technique
11.3.7.1.4 Australia Metabolic Biomarker Testing Market by End-User
11.3.7.2 China Metabolic Biomarker Testing Market
11.3.7.2.1 China Metabolic Biomarker Testing Market by Indication
11.3.7.2.2 China Metabolic Biomarker Testing Market by Application
11.3.7.2.3 China Metabolic Biomarker Testing Market by Technique
11.3.7.2.4 China Metabolic Biomarker Testing Market by End-User
11.3.7.3 India Metabolic Biomarker Testing Market
11.3.7.3.1 India Metabolic Biomarker Testing Market by Indication
11.3.7.3.2 India Metabolic Biomarker Testing Market by Application
11.3.7.3.3 India Metabolic Biomarker Testing Market by Technique
11.3.7.3.4 India Metabolic Biomarker Testing Market by End-User
11.3.7.4 Japan Metabolic Biomarker Testing Market
11.3.7.4.1 Japan Metabolic Biomarker Testing Market by Indication
11.3.7.4.2 Japan Metabolic Biomarker Testing Market by Application
11.3.7.4.3 Japan Metabolic Biomarker Testing Market by Technique
11.3.7.4.4 Japan Metabolic Biomarker Testing Market by End-User
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Metabolic Biomarker Testing Market Overview
11.4.2 Middle East and Africa Metabolic Biomarker Testing Market Forecasts and Analysis
11.4.3 Middle East and Africa Metabolic Biomarker Testing Market Forecasts and Analysis - By Indication
11.4.4 Middle East and Africa Metabolic Biomarker Testing Market Forecasts and Analysis - By Application
11.4.5 Middle East and Africa Metabolic Biomarker Testing Market Forecasts and Analysis - By Technique
11.4.6 Middle East and Africa Metabolic Biomarker Testing Market Forecasts and Analysis - By End-User
11.4.7 Middle East and Africa Metabolic Biomarker Testing Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Metabolic Biomarker Testing Market
11.4.7.1.1 South Africa Metabolic Biomarker Testing Market by Indication
11.4.7.1.2 South Africa Metabolic Biomarker Testing Market by Application
11.4.7.1.3 South Africa Metabolic Biomarker Testing Market by Technique
11.4.7.1.4 South Africa Metabolic Biomarker Testing Market by End-User
11.4.7.2 Saudi Arabia Metabolic Biomarker Testing Market
11.4.7.2.1 Saudi Arabia Metabolic Biomarker Testing Market by Indication
11.4.7.2.2 Saudi Arabia Metabolic Biomarker Testing Market by Application
11.4.7.2.3 Saudi Arabia Metabolic Biomarker Testing Market by Technique
11.4.7.2.4 Saudi Arabia Metabolic Biomarker Testing Market by End-User
11.4.7.3 U.A.E Metabolic Biomarker Testing Market
11.4.7.3.1 U.A.E Metabolic Biomarker Testing Market by Indication
11.4.7.3.2 U.A.E Metabolic Biomarker Testing Market by Application
11.4.7.3.3 U.A.E Metabolic Biomarker Testing Market by Technique
11.4.7.3.4 U.A.E Metabolic Biomarker Testing Market by End-User
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Metabolic Biomarker Testing Market Overview
11.5.2 South and Central America Metabolic Biomarker Testing Market Forecasts and Analysis
11.5.3 South and Central America Metabolic Biomarker Testing Market Forecasts and Analysis - By Indication
11.5.4 South and Central America Metabolic Biomarker Testing Market Forecasts and Analysis - By Application
11.5.5 South and Central America Metabolic Biomarker Testing Market Forecasts and Analysis - By Technique
11.5.6 South and Central America Metabolic Biomarker Testing Market Forecasts and Analysis - By End-User
11.5.7 South and Central America Metabolic Biomarker Testing Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Metabolic Biomarker Testing Market
11.5.7.1.1 Brazil Metabolic Biomarker Testing Market by Indication
11.5.7.1.2 Brazil Metabolic Biomarker Testing Market by Application
11.5.7.1.3 Brazil Metabolic Biomarker Testing Market by Technique
11.5.7.1.4 Brazil Metabolic Biomarker Testing Market by End-User
11.5.7.2 Argentina Metabolic Biomarker Testing Market
11.5.7.2.1 Argentina Metabolic Biomarker Testing Market by Indication
11.5.7.2.2 Argentina Metabolic Biomarker Testing Market by Application
11.5.7.2.3 Argentina Metabolic Biomarker Testing Market by Technique
11.5.7.2.4 Argentina Metabolic Biomarker Testing Market by End-User
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. METABOLIC BIOMARKER TESTING MARKET, KEY COMPANY PROFILES
13.1. BIO-RAD LABORATORIES, INC
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. BRUKER CORPORATION
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. DANAHER CORPORATION
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. AGILENT TECHNOLOGIES
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. THERMO FISHER SCIENTIFIC, INC
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. HUMAN METABOLOME TECHNOLOGIES INC
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. LECO CORPORATION
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. SHIMADZU CORPORATION
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. BIOCRATES LIFE SCIENCES AG
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. WATERS CORPORATION
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies
- Bio-Rad Laboratories, Inc
- Bruker Corporation
- Danaher Corporation
- Agilent Technologies
- Thermo Fisher Scientific, Inc
- Human Metabolome Technologies Inc
- LECO Corporation
- Shimadzu Corporation
- Biocrates Life Sciences AG
- Waters Corporation
- Bio-Rad Laboratories, Inc
- Bruker Corporation
- Danaher Corporation
- Agilent Technologies
- Thermo Fisher Scientific, Inc
- Human Metabolome Technologies Inc
- LECO Corporation
- Shimadzu Corporation
- Biocrates Life Sciences AG
- Waters Corporation